Alendronic acid [Binosto] and levothyroxine sodium [Synthroid] co-administration.

Trial Profile

Alendronic acid [Binosto] and levothyroxine sodium [Synthroid] co-administration.

Phase of Trial: Phase II

Latest Information Update: 25 May 2015

At a glance

  • Drugs Alendronic acid (Primary) ; Levothyroxine sodium (Primary)
  • Indications Hypothyroidism; Osteoporosis
  • Focus Pharmacokinetics
  • Most Recent Events

    • 25 May 2015 New trial record
    • 08 Mar 2015 Results presented at The 97th Annual Meeting of the Endocrine Society.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top